During the past decade, Chengdu Fifth People's Hospital conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 2 clinical trials were completed, i.e. on average, 22.2% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 2 clinical trials were completed. i.e. 28.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Chengdu Fifth People's Hospital" #1 sponsor was "Eli Lilly and Company" with 3 trials, followed by "Sichuan Cancer Hospital and Research Institute" with 2 trials sponsored, "Guangdong Raynovent Biotech Co., Ltd" with 1 trials sponsored, "PegBio Co., Ltd." with 1 trials sponsored and "Sichuan Academy of Medical Sciences" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Chengdu Fifth People's Hospital" #1 collaborator was "Chia Tai Tianqing Pharmaceutical Group Co., Ltd." with 2 trials as a collaborator and "Sichuan Provincial People's Hospital" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Chengdu Fifth People's Hospital" are "Lung Cancer Metastatic" (2 trials), "Type 2 Diabetes" (2 trials), "Abnormal Mucus Secretions" (1 trials), "Acute Ischemic Stroke" (1 trials) and "Alteplase" (1 trials). Many other conditions were trialed in "Chengdu Fifth People's Hospital" in a lesser frequency.

Most popular intervention types in "Chengdu Fifth People's Hospital" are "Drug" (9 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Tirzepatide" (2 trials), "Ambroxol hydrochloride 30 mg" (1 trials), "Anlotinib Hydrochloride" (1 trials) and "Docetaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Chengdu Fifth People's Hospital" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Chengdu Fifth People's Hospital". 1 are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Chengdu Fifth People's Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Chengdu Fifth People's Hospital, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".